Abstract
Treatment objectives of cutaneous T-cell lymphoma can be achieved with a variety of modalities applied to the variable presentations of the disease. In this review, the goals of therapy are presented and each therapy is summarized in terms of its use to achieve those goals. After reviewing the modalities, the strategies are summarized in reference to each presentation of cutaneous T-cell lymphoma.
Financial & competing interests disclosure
Heald is on the speakers bureau of both Eisai, Inc. and Therakos, Inc.. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.